Search Results - "Tornin, Juan"

Refine Results
  1. 1

    Evaluation of the effects of cold atmospheric plasma and plasma-treated liquids in cancer cell cultures by Tornin, Juan, Labay, Cédric, Tampieri, Francesco, Ginebra, Maria-Pau, Canal, Cristina

    Published in Nature protocols (01-06-2021)
    “…Cold atmospheric plasma (CAP) is a potential anticancer therapy. CAP has cytotoxic effects when applied either directly to cancer cell cultures or indirectly…”
    Get full text
    Journal Article
  2. 2

    Pyruvate Plays a Main Role in the Antitumoral Selectivity of Cold Atmospheric Plasma in Osteosarcoma by Tornin, Juan, Mateu-Sanz, Miguel, Rodríguez, Aida, Labay, Cédric, Rodríguez, Rene, Canal, Cristina

    Published in Scientific reports (23-07-2019)
    “…Osteosarcoma (OS) is the most common primary bone tumor but current therapies still have poor prognosis. Cold Atmospheric Plasma (CAP) and Plasma activated…”
    Get full text
    Journal Article Publication
  3. 3

    Osteosarcoma: Cells-of-Origin, Cancer Stem Cells, and Targeted Therapies by Rodriguez, Rene, Garcia-Castro, Javier, González, M. Victoria, Rodrigo, Juan P., Martinez-Campos, Enrique, Hamilton, Ashley, Martinez-Cruzado, Lucia, Tornin, Juan, Abarrategi, Ander, Baldini, Nicola

    Published in Stem cells international (01-01-2016)
    “…Osteosarcoma (OS) is the most common type of primary solid tumor that develops in bone. Although standard chemotherapy has significantly improved long-term…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Expression of FUS‐CHOP fusion protein in immortalized/transformed human mesenchymal stem cells drives mixoid liposarcoma formation by Rodriguez, Rene, Tornin, Juan, Suarez, Carlos, Astudillo, Aurora, Rubio, Ruth, Yauk, Carole, Williams, Andrew, Rosu‐Myles, Michael, Funes, Juan M., Boshoff, Chris, Menendez, Pablo

    Published in Stem cells (Dayton, Ohio) (01-10-2013)
    “…Increasing evidence supports that mesenchymal stromal/stem cells (MSCs) may represent the target cell for sarcoma development. Although different sarcomas have…”
    Get full text
    Journal Article
  6. 6

    Trabectedin and Campthotecin Synergistically Eliminate Cancer Stem Cells in Cell-of-Origin Sarcoma Models by Martinez-Cruzado, Lucia, Tornin, Juan, Rodriguez, Aida, Santos, Laura, Allonca, Eva, Fernandez-Garcia, Maria Teresa, Astudillo, Aurora, Garcia-Pedrero, Juana Maria, Rodriguez, Rene

    Published in Neoplasia (New York, N.Y.) (01-06-2017)
    “…Abstract Trabectedin has been approved for second-line treatment of soft tissue sarcomas. However, its efficacy to target sarcoma initiating cells has not been…”
    Get full text
    Journal Article
  7. 7

    Inhibition of SP1 by the mithramycin analog EC-8042 efficiently targets tumor initiating cells in sarcoma by Tornin, Juan, Martinez-Cruzado, Lucia, Santos, Laura, Rodriguez, Aida, Núñez, Luz-Elena, Oro, Patricia, Hermosilla, Maria Ana, Allonca, Eva, Fernández-García, Maria Teresa, Astudillo, Aurora, Suarez, Carlos, Morís, Francisco, Rodriguez, Rene

    Published in Oncotarget (24-05-2016)
    “…Tumor initiating cells (TICs), responsible for tumor initiation, and cancer stem cells (CSCs), responsible for tumor expansion and propagation, are often…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Cold atmospheric plasma enhances doxorubicin selectivity in metastasic bone cancer by Mateu-Sanz, Miguel, Ginebra, María-Pau, Tornín, Juan, Canal, Cristina

    Published in Free radical biology & medicine (20-08-2022)
    “…High-dose systemic chemotherapy constitutes a main strategy in the management of bone metastases, employing drugs like doxorubicin (DOX), related with severe…”
    Get full text
    Journal Article
  13. 13

    Osteosarcoma tissue-engineered model challenges oxidative stress therapy revealing promoted cancer stem cell properties by Tornín, Juan, Villasante, Aranzazu, Solé-Martí, Xavi, Ginebra, Maria-Pau, Canal, Cristina

    Published in Free radical biology & medicine (20-02-2021)
    “…The use of oxidative stress generated by Cold Atmospheric Plasma (CAP) in oncology is being recently studied as a novel potential anti-cancer therapy. However,…”
    Get full text
    Journal Article
  14. 14

    Exploring the Use of Cold Atmospheric Plasma to Overcome Drug Resistance in Cancer by Murillo, Dzohara, Huergo, Carmen, Gallego, Borja, Rodríguez, René, Tornín, Juan

    Published in Biomedicines (14-01-2023)
    “…Drug resistance is a major problem in cancer treatment, as it limits the effectiveness of pharmacological agents and can lead to disease progression. Cold…”
    Get full text
    Journal Article
  15. 15

    Cold Plasma-Treated Ringer's Saline: A Weapon to Target Osteosarcoma by Mateu-Sanz, Miguel, Tornín, Juan, Brulin, Bénédicte, Khlyustova, Anna, Ginebra, Maria-Pau, Layrolle, Pierre, Canal, Cristina

    Published in Cancers (17-01-2020)
    “…Osteosarcoma (OS) is the main primary bone cancer, presenting poor prognosis and difficult treatment. An innovative therapy may be found in cold plasmas, which…”
    Get full text
    Journal Article Publication
  16. 16

    Cold plasma-treated medium preferentially eliminates doxorubicin-resistant osteosarcoma cells by Tornín, Juan, Gallego, Borja, Rey, Verónica, Murillo, Dzohara, Huergo, Carmen, Rodríguez, Aida, Canal, Cristina, Rodríguez, René

    Published in Free radical biology & medicine (20-11-2023)
    “…Osteosarcoma (OS) is an aggressive bone cancer with poor prognosis, largely due to the limited effectiveness of current treatments such as doxorubicin (DX)…”
    Get full text
    Journal Article
  17. 17

    Cold Atmospheric Plasma: A New Strategy Based Primarily on Oxidative Stress for Osteosarcoma Therapy by Mateu-Sanz, Miguel, Tornín, Juan, Ginebra, Maria-Pau, Canal, Cristina

    Published in Journal of clinical medicine (23-02-2021)
    “…Osteosarcoma is the most common primary bone tumor, and its first line of treatment presents a high failure rate. The 5-year survival for children and…”
    Get full text
    Journal Article
  18. 18

    Addressing Doxorubicin Resistance in Bone Sarcomas Using Novel Drug-Resistant Models by Gallego, Borja, Murillo, Dzohara, Rey, Verónica, Huergo, Carmen, Estupiñán, Óscar, Rodríguez, Aida, Tornín, Juan, Rodríguez, René

    “…Bone sarcomas have not shown a significant improvement in survival for decades, due, in part, to the development of resistance to current systemic treatments,…”
    Get full text
    Journal Article
  19. 19

    Cold plasma and inhibition of STAT3 selectively target tumorigenicity in osteosarcoma by Tornín, Juan, Mateu-Sanz, Miguel, Rey, Verónica, Murillo, Dzohara, Huergo, Carmen, Gallego, Borja, Rodríguez, Aida, Rodríguez, René, Canal, Cristina

    Published in Redox biology (01-06-2023)
    “…Osteosarcoma (OS) is a malignant type of bone cancer that arises in periods of increased bone formation. Curative strategies for these types of tumors have…”
    Get full text
    Journal Article
  20. 20